These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study. Mustonen P; Lehtonen KV; Javela K; Puurunen M Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304 [TBL] [Abstract][Full Text] [Related]
3. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome? Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448 [TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies: evaluation of the thrombotic risk. Devreese KM Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657 [TBL] [Abstract][Full Text] [Related]
5. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays. Chayoua W; Kelchtermans H; Moore GW; Musiał J; Wahl D; de Laat B; Devreese KMJ J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628 [TBL] [Abstract][Full Text] [Related]
6. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements. Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome. Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116 [TBL] [Abstract][Full Text] [Related]
8. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [TBL] [Abstract][Full Text] [Related]
9. Antibody profiles for the diagnosis of antiphospholipid syndrome. Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401 [TBL] [Abstract][Full Text] [Related]
10. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome. Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022 [TBL] [Abstract][Full Text] [Related]
11. [Laboratory examinations in antiphospholipid syndrome]. Ieko M; Naito S; Yoshida M Rinsho Byori; 2010 Apr; 58(4):343-51. PubMed ID: 20496762 [TBL] [Abstract][Full Text] [Related]
12. Interpretation and recommended testing for antiphospholipid antibodies. Galli M Semin Thromb Hemost; 2012 Jun; 38(4):348-52. PubMed ID: 22399305 [TBL] [Abstract][Full Text] [Related]
13. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk. Egri N; Bentow C; Rubio L; Norman GL; López-Sañudo S; Mahler M; Pérez-Isidro A; Cervera R; Viñas O; Espinosa G; Ruiz-Ortiz E Front Immunol; 2021; 12():754469. PubMed ID: 34790198 [TBL] [Abstract][Full Text] [Related]
14. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome. Forastiero R; Martinuzzo M Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486 [TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies in patients with COVID-19: A relevant observation? Devreese KMJ; Linskens EA; Benoit D; Peperstraete H J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328 [TBL] [Abstract][Full Text] [Related]
16. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis? Bardin N; Alessi MC; Dignat-George F; Vague IJ; Sampol J; Harlé JR; Sanmarco M Immunobiology; 2007; 212(7):557-65. PubMed ID: 17678713 [TBL] [Abstract][Full Text] [Related]
17. Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome. Mondejar R; González-Rodríguez C; Toyos-Sáenz de Miera FJ; Melguizo-Madrid E; Zohoury N; Mahler M; Romero Losquiño I; Fabiani F Clin Chim Acta; 2014 Apr; 431():174-8. PubMed ID: 24522162 [TBL] [Abstract][Full Text] [Related]
18. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome. Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605 [TBL] [Abstract][Full Text] [Related]
19. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts? Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307 [TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients. Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E Lupus; 2007; 16(1):39-45. PubMed ID: 17283584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]